Tim Heffernan

Tim Heffernan

Company: MD Anderson Cancer Center- Translational Research to Advance Therapeutics & Innovation in Oncology

Job title: Executive Director, Oncology Research

Seminars:

Translational Case Study: Translational Development of IACS-6274, a Potent and Selective Glutaminase (GLS1) Inhibitor in Phase 1 Trials for Molecularly-Defined Subsets of Patients with Advanced Solid Tumors 8:00 am

IACS-6274 is a potent, selective inhibitor of GLS1, that has excellent physicochemical properties and demonstrates selective anti-tumor effects in subsets of ovarian cancer and non-small cell lung cancers Through a comprehensive translational effort, we uncovered a reliance on GLS1 driven by unique cellular dependencies and identified clinically actionable patient stratification biomarkers An integrated approach that…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.